uniQure (QURE) Intangibles (2015 - 2026)
uniQure (QURE) posted quarterly Intangibles of $62.1 million for Q2 2026, down 17.86% year-over-year from $75.6 million in Q2 2025, and down 11.27% quarter-over-quarter from $70.0 million in Q1 2026.
uniQure (QURE) Intangibles (2015 - 2026) Analysis & Trends
uniQure's Intangibles history runs 12 years deep, the most recent figure standing at $62.1 million for Q2 2026.
- In Q2 2026, Intangibles fell 17.86% year-over-year to $62.1 million; the TTM figure through Jun 2026 stood at $62.1 million (down 17.86% YoY), while the FY2025 annual figure was $72.8 million, down 2.44% from the prior year.
- Intangibles for Q2 2026 stood at $62.1 million, down from $70.0 million in the prior quarter.
- The five-year high for Intangibles was $76.6 million in Q3 2024, with the low at $53.8 million in Q3 2022.
- The 5-year median for Intangibles is $61.3 million (2022), against an average of $64.8 million.
- The sharpest annual moves came in 2022 and 2026: Intangibles soared 2078.61% in 2022, then decreased 17.86% in 2026.
- uniQure's Intangibles stood at $58.8 million in 2022, then gained by 4.7% to $61.5 million in 2023, then grew by 21.25% to $74.6 million in 2024, then decreased by 2.44% to $72.8 million in 2025, then decreased by 14.68% to $62.1 million in 2026.
- Business Quant data shows QURE's Intangibles at $62.1 million in Q2 2026, $70.0 million in Q1 2026, and $72.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 62.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.10 Mn |
| Mar 31, 2026 | 69.99 Mn |
| Dec 31, 2025 | 72.79 Mn |
| Sep 30, 2025 | 74.14 Mn |
| Jun 30, 2025 | 75.60 Mn |
| Mar 31, 2025 | 71.99 Mn |
| Dec 31, 2024 | 74.61 Mn |
| Sep 30, 2024 | 76.61 Mn |
| Jun 30, 2024 | 58.66 Mn |
| Mar 31, 2024 | 59.11 Mn |
| Dec 31, 2023 | 61.54 Mn |
| Sep 30, 2023 | 57.98 Mn |
| Jun 30, 2023 | 59.71 Mn |
| Mar 31, 2023 | 59.70 Mn |
| Dec 31, 2022 | 58.78 Mn |
| Sep 30, 2022 | 53.84 Mn |
| Jun 30, 2022 | 57.45 Mn |
| Mar 31, 2022 | 61.14 Mn |
| Dec 31, 2021 | 62.69 Mn |
| Sep 30, 2021 | 64.01 Mn |